Book Review: Pediatric Hospital Medicine: Textbook of Inpatient Management

Hope Medicine's HMI-115 is expected to be released in 2027, with phase 3 trials currently recruiting. Concerns include the safety of targeting prolactin and the potential cost of the treatment.

High doses of oral minoxidil in the 1980s often led to significant body hair growth but not proportionally more scalp hair compared to lower doses. The treatment also caused cardiovascular side effects, making it unsuitable for hair loss experiments.

A manager told an employee to stop using minoxidil, fearing it could unintentionally cause hair growth in others. The conversation is filled with humorous and sarcastic responses, questioning the manager's logic and suggesting the employee continue using the treatment secretly.

A 16-year-old diagnosed with male pattern baldness (MPB) was prescribed hair vitamins, vitamin D, a non-ketoconazole shampoo, and redenysl + serum, with a suggestion for GFC or IHRF treatments. Some users recommended minoxidil, ketoconazole, and derma stamping, while others advised against certain treatments until the age of 18.

A 21-year-old is experiencing hair loss despite using finasteride, minoxidil, derma rolling, vitamins, and keto shampoo. They are contemplating a hair transplant but worry about their age and future hair loss.

A 15-year-old experiencing hair loss and anxiety is using minoxidil and microneedling but is advised against starting finasteride or dutasteride due to age. The discussion emphasizes consulting a doctor, considering hormonal evaluations, and exploring non-medication coping strategies.